BATTINI, VERA
BATTINI, VERA
Dipartimento di Scienze Biomediche e Cliniche
Timing Matters: A Machine Learning Method for the Prioritization of Drug–Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure
2024 V. Battini, M. Cocco, M.A. Barbieri, G. Powell, C. Carnovale, E. Clementi, A. Bate, M. Sessa
Artificial intelligence for the optimal management of community-acquired pneumonia
2024 M.A. Barbieri, V. Battini, M. Sessa
The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration
2024 M. Fusaroli, F. Salvo, B. Begaud, T.M. Alshammari, A. Bate, V. Battini, A. Brueckner, G. Candore, C. Carnovale, S. Crisafulli, P.M. Cutroneo, C. Dolladille, M. Drici, J. Faillie, A. Goldman, M. Hauben, M.T. Herdeiro, O. Mahaux, K. Manlik, F. Montastruc, Y. Noguchi, G.N. Norén, R. Noseda, I.J. Onakpoya, A. Pariente, E. Poluzzi, M. Salem, D. Sartori, N.T.H. Trinh, M. Tuccori, F. van Hunsel, E. van Puijenbroek, E. Raschi, C. Khouri
The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement
2024 M. Fusaroli, F. Salvo, B. Begaud, T.M. Alshammari, A. Bate, V. Battini, A. Brueckner, G. Candore, C. Carnovale, S. Crisafulli, P.M. Cutroneo, C. Dolladille, M. Drici, J. Faillie, A. Goldman, M. Hauben, M.T. Herdeiro, O. Mahaux, K. Manlik, F. Montastruc, Y. Noguchi, G.N. Norén, R. Noseda, I.J. Onakpoya, A. Pariente, E. Poluzzi, M. Salem, D. Sartori, N.T.H. Trinh, M. Tuccori, F. van Hunsel, E. van Puijenbroek, E. Raschi, C. Khouri
Drug Repurposing in Crohn’s Disease Using Danish Real-World Data
2024 S. Shakibfar, K. Allin, T. Jess, M.A. Barbieri, V. Battini, E. Simoncic, J. Kirchgesner, T. Ulven, M. Sessa
Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS
2024 M. Fusaroli, V. Giunchi, V. Battini, S. Puligheddu, C. Khouri, C. Carnovale, E. Raschi, E. Poluzzi
Exploring the impact of co-exposure timing on drug-drug interactions in signal detection through spontaneous reporting system databases: a scoping review
2024 M. Cocco, C. Carnovale, E. Clementi, M.A. Barbieri, V. Battini, M. Sessa
THE ROLE OF HYPOGLYCEMIC AGENTS IN AMELIORATING COGNITIVE FUNCTIONS AND PSYCHIATRIC SYMPTOMS: FROM THE PSYCHIATRIC PATIENT TO EVIDENCE-BASED AND PHARMACOEPIDEMIOLOGIC APPROACHES FOR SUPPORTING THE CLINICAL PRACTICE
2024 V. Battini
Comparing major and mild cognitive impairment risks in older type-2 diabetic patients: a Danish register-based study on dipeptidyl peptidase-4 inhibitors vs. glucagon-like peptide-1 analogues
2024 V. Battini, M.A. Barbieri, C. Carnovale, E. Spina, E. Clementi, M. Sessa
Evaluating the 6-month formulation of paliperidone palmitate: a twice-yearly injectable treatment for schizophrenia in adults
2024 G. Cirnigliaro, V. Battini, M. Castiglioni, M. Renne, G. Mosini, S. Cheli, C. Carnovale, B. Dell'Osso
On the potential of drug repurposing in dysphagia treatment: New insights from a real-world pharmacovigilance study and a systematic review
2023 V. Battini, S. Rocca, G. Guarnieri, A. Bombelli, M. Gringeri, G. Mosini, M. Pozzi, M. Nobile, S. Radice, E. Clementi, A. Schindler, C. Carnovale, N. Pizzorni
Ubrogepant and rimegepant: signal detection using spontaneous reports of adverse events from the Food and Drug Administration Adverse Event Reporting System
2023 V. Battini, C. Carnovale, E. Clementi, M. Sessa
Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study
2023 M. Fusaroli, V. Giunchi, V. Battini, M. Gringeri, R. Rimondini, M. Menchetti, S. Radice, M. Pozzi, M. Nobile, E. Clementi, F. De Ponti, C. Carnovale, E. Raschi, E. Poluzzi
Barriers to the use of three-month Paliperidone Palmitate formulation: a study from an Italian real-world setting
2023 G. Cirnigliaro, V. Battini, R. Cafaro, G. Mosini, S. Vanzetto, T. Prodi, M. Macellaro, R. Leuzzi, D. Conti, C. Carnovale, B. Dell'Osso
Psychiatric and non-psychiatric drugs causing false-positive amphetamines urine test in psychiatric patients: a pharmacovigilance analysis using FAERS
2023 V. Battini, G. Cirnigliaro, L. Giacovelli, M. Boscacci, S. MASSARA MANZO, G. Mosini, G. Guarnieri, M. Gringeri, B. Benatti, E.G.I. Clementi, D. Bernardo, C. Carnovale
Umbrella Review: Association Between Antipsychotic Drugs and Metabolic Syndrome Hallmarks in Children and Adolescents
2023 C. Carnovale, V. Battini, C. Santoro, M.P. Riccio, S. Carucci, M. Nobile, P. Formisano, C. Bravaccio, A. Zuddas, E. Clementi, M. Pozzi, S. Pisano
A novel approach for pharmacological substantiation of safety signals using plasma concentrations of medication and administrative/healthcare databases: A case study using Danish registries for an FDA warning on lamotrigine
2023 W. Wang, V. Battini, C. Carnovale, R. Noordam, K.W. van Dijk, K.H. Kragholm, D. van Heemst, H. Soeorg, M. Sessa
The potential antidepressant effect of antidiabetic agents: New insights from a pharmacovigilance study based on data from the reporting system databases FAERS and VigiBase
2023 V. Battini, R.P. Van Manen, M. Gringeri, G. Mosini, G. Guarnieri, A. Bombelli, M. Pozzi, M. Nobile, S. Radice, E. Clementi, C. Carnovale
The potential effect of metformin on cognitive and other symptom dimensions in patients with schizophrenia and antipsychotic-induced weight gain: a systematic review, meta-analysis, and meta-regression
2023 V. Battini, G. Cirnigliaro, R. Leuzzi, E. Rissotto, G. Mosini, B. Benatti, M. Pozzi, M. Nobile, S. Radice, C. Carnovale, B. Dell'Osso, E. Clementi
Safety of fexofenadine and other second-generation oral antihistamines before and after the removal of the prescription requirement in Italy and other European countries: A real-world evidence study and systematic review
2022 C. Carnovale, V. Battini, M. Gringeri, M. Volonté, M.C. Uboldi, A. Chiarenza, G. Passalacqua